Dr. Ramon Quesada, MD
Claim this profileBaptist Hospital of Miami
Affiliated Hospitals
Baptist Hospital Of Miami
Baptist Health South Florida
Clinical Trials Ramon Quesada, MD is currently running
PCI vs Medical Management
for Aortic Stenosis
Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise regarding the management of concomitant CAD in patients undergoing TAVR. Some centers perform routine revascularization with percutaneous coronary intervention (PCI) (either before or after TAVR), while others follow an alternative strategy of medical management. The potential benefits and optimal timing of PCI in these patients are unknown. As TAVR expands to lower risk patients, and potentially becomes the preferred therapy for the majority of patients with severe aortic stenosis, the optimal management of concomitant coronary artery disease will be of increasing importance. The COMPLETE TAVR study will determine whether, on a background of guideline-directed medical therapy, a strategy of complete revascularization involving staged PCI using drug eluting stents to treat all suitable coronary artery lesions is superior to a strategy of medical therapy alone in reducing the composite outcome of Cardiovascular Death, new Myocardial Infarction, Ischemia-driven Revascularization or Hospitalization for Unstable Angina or Heart Failure. The study will be a randomized, multicenter, open-label trial with blinded adjudication of outcomes. Patients will be screened and consented for elective transfemoral TAVR and randomized within 96 hours of successful balloon expandable TAVR. Complete Revascularization: Staged PCI using third generation drug eluting stents to treat all suitable coronary artery lesions in vessels that are at least 2.5 mm in diameter and that are amenable to treatment with PCI and have a ≥70% visual angiographic diameter stenosis. Staged PCI can occur any time from 1 to 45 days post successful transfemoral TAVR. Vs. Medical Therapy Alone: No further revascularization of coronary artery lesions. All patients, regardless of randomized treatment allocation, will receive guideline-directed medical therapy consisting of risk factor modification and use of evidence-based therapies. The COMPLETE TAVR study will help address the current lack of evidence in this area. It will likely impact both the global delivery of health care and the management and clinical outcomes of all patients undergoing TAVR with concomitant CAD.
Recruiting
1 award
N/A
4 criteria
Carillon Device
for Heart Failure with Mitral Regurgitation
This trial is testing a device called the Carillon Mitral Contour System, which helps the mitral valve in the heart work better. It targets patients with heart failure and a specific valve problem. The device reshapes the valve to improve its function and reduce symptoms.
Recruiting
1 award
N/A
2 criteria
More about Ramon Quesada, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ramon Quesada, MD has experience with
- Revivent TC
- WATCHMAN FLX LAAC Device
- Non-Vitamin K Oral Anticoagulant
- Carillon Mitral Contour System
- PCI + Impella
- SSO2 Downstream System
Breakdown of trials Ramon Quesada, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ramon Quesada, MD specialize in?
Ramon Quesada, MD focuses on Bleeding and Stroke. In particular, much of their work with Bleeding has involved treating patients, or patients who are undergoing treatment.
Is Ramon Quesada, MD currently recruiting for clinical trials?
Yes, Ramon Quesada, MD is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Ramon Quesada, MD has studied deeply?
Yes, Ramon Quesada, MD has studied treatments such as Revivent TC, WATCHMAN FLX LAAC Device, Non-Vitamin K Oral Anticoagulant.
What is the best way to schedule an appointment with Ramon Quesada, MD?
Apply for one of the trials that Ramon Quesada, MD is conducting.
What is the office address of Ramon Quesada, MD?
The office of Ramon Quesada, MD is located at: Baptist Hospital of Miami, Miami, Florida 33176 United States. This is the address for their practice at the Baptist Hospital of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.